CONSISTENCY STUDY OF GLAXOSMITHKLINE (GSK) BIOLOGICALS' MMR VACCINE (209762) (PRIORIX®) COMPARING IMMUNOGENICITY AND SAFETY TO MERCK & CO., INC.'S MMR VACCINE (M M R®II), IN CHILDREN 12 TO 15 MONTHS OF AGE: